Indaptus Therapeutics, Inc. (INDP) Tops Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts INDP Hot Sheet
Join SI Premium – FREE
Indaptus Therapeutics, Inc. (NASDAQ: INDP) reported Q2 EPS of ($0.47), $0.11 better than the analyst estimate of ($0.58).
For earnings history and earnings-related data on Indaptus Therapeutics, Inc. (INDP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Evolution Petroleum to buy Midland Basin mineral rights for $16M
- Freedom Broker Downgrades Flexsteel (FLXS) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
